ANDA 40576, held by Accelrx Labs. Carisoprodol.
As of Nov 16, 2026, ANDA 40576 (Carisoprodol), held by Accelrx Labs, was first approved by FDA on Jun 7, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 7, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carisoprodol350MG ยท tablet;oral | Carisoprodol | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters